Report for Q3 2024

About this update from Mayinglong Pharmaceutical Group Co., Ltd. Class A

Report for Q3 2024The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Mayinglong Pharmaceutical Group Co., Ltd. Class A